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Abstract
Purpose: The purpose of this study was to develop a tool for functional phenotyping of the
maternal circulation in the mouse placenta.
Procedures: In utero macromolecular dynamic contrast-enhanced magnetic resonance imaging
(DCE-MRI) was performed on embryonic day 10.5 (E10.5), E13.5, and E18.5. Fluorescence
analysis was also used for validation of the results.
Results: The initial rate of contrast enhancement revealed an increased maternal blood volume
fraction as the pregnancy progressed. Serial imaging of E10.5 and E13.5 placentas revealed a
loss of contrast enhancement due to phagocytic uptake. A key application of macromolecular
DCE-MRI would be to follow mouse pregnancies during fetal and placental manipulation
including embryo transfer, tetraploid complementation, and fetal resorptions. We were able to
resolve strain differences in ICR outbred mice carrying both ICR and C57Bl/6J embryos and to
differentiate in utero resorptions from functional placentas.
Conclusions: Our results highlight the importance of the functional in utero analysis of placental
vascularization in physiological phenotyping of transgenic mice and suggest MRI, particularly
macromolecular DCE-MRI, as a non-invasive tool for the analysis of the placenta.
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Mouse model
Introduction
The mouse is widely used as a model animal for theidentification of mammalian genes and analysis of their
role in both health and disease. The genomic and physio-
logical similarities between mice and humans lead to the use
of the mouse model as a research tool to test suggested
therapies of human diseases. Taking advantage of the known
mouse genomic sequence, a growing scientific effort is
currently being made in order to generate knockouts for each
of the mouse genes, providing a tool for the identification of
their role and function [1]. A variety of additional tools is
being exploited for genomic manipulation, including: (1)
gene overexpression, (2) knock-in strategies, (3) reporter
gene insertions, and (4) generation of conditional transgenic
mice, emphasizing the need to study gene specific functions
in the context of the specific organ in question. In this
respect, tetraploid placenta complementation, in which an
embryo can be complemented with a placenta of a different
genetic composition, enables the assessment of the role of a
Significance: Functional phenotyping of the placenta is critical for under-
standing the impact of genetic manipulations on fetal development.
Molecular imaging was applied here for noninvasive mapping of the
recycling of maternal plasma albumin in the mouse placenta.
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gene in embryonic versus extra-embryonic tissues (such as
the placenta). In addition, tetraploid complementation can be
used to prevent in utero death of embryos due to placental
malfunction. The method involves aggregation of electrofused
tetraploid pre-implantation embryos with embryonic stem cells
(or inner cell mass), resulting in the development of the extra-
embryonic lineages (including the placenta) from the tetraploid
embryo and embryonic lineages from the embryonic stem
cells. In this way, it is possible to generate an embryo with a
specific genetic background supported by extra-embryonic
tissues of another genetic background [2, 3, 5].
Side by side with the increased availability of genetically
modified mice, an effort is being made to develop method-
ologies for the phenotypic analysis of newly formed animal
models. Basic phenotype screening programs typically
include behavioral observation, assessment of developmen-
tal lethality, physical examination, and blood tests [1].
However, a more detailed analysis is needed in order to
fully understand the role and function of the gene of interest.
Non-invasive analyses which do not hamper the viability of
the mouse model in question bear an obvious advantage.
The aim of this study was to develop a novel tool for the
phenotypic analysis of mouse development in utero, with
emphasis on the placenta. The importance of the mammalian
placenta is derived from the fundamental role it has in
exchange of respiratory gases, nutrients, and wastes between
the maternal and fetal vascular systems [6–10]. The insight
on the maternal and fetal circulation of the mouse placenta
was enhanced by an elegant application of vascular casts
[11]. The analogy between the structure and function of the
mouse and human placenta was carefully examined by
histopathology, suggesting multiple similarities in structure
and function, despite specific differences [12].
We previously applied blood oxygen level-dependent
magnetic resonance imaging (MRI) to non-invasively monitor
hypoxia induced by cloprostenol, a prostaglandin F(2alpha)
analog, in the rat embryo placental unit [13]. Additionally,
macromolecular dynamic contrast-enhanced (DCE)MRI using
biotin–bovine serum albumin (BSA)–Gd–DTPA was applied
for the in vivo characterization of vascular function in tumors
[14, 15], in ovarian grafts [16], and during embryo implanta-
tion [17]. In these studies, biotin–BSA–Gd–DTPA selectively
extravasated from areas where the vessel permeability was
high, such as tumors, embryo implantation sites, and ovaries,
and allowed non-invasive imaging of these areas of interest.
Biotin–BSA–Gd–DTPA provides a complementary ability for
the validation of the biodistribution of the MRI contrast agent
in histological sections by labeling with avidin-Texas red.
However, in contrast to low molecular weight gadolinium
chelates, albumin does not cross the placenta barrier in normal
situations and, thus, the analysis of maternal circulation in the
placenta is not confounded by transfer to the fetal circulation,
as is seen with Gd–DTPA [18, 19].
In this study, we evaluated in utero normal placentas at
different developmental stages and resolved strain-specific
differences. At the first stage of analysis (E10.5), the
chorioallantoic placenta had reached its basic three-layer
structure. The placenta continues its expansion and rearrange-
ment throughout pregnancy (E13.5) and supplies the needs of
the embryo until the end of the pregnancy (E18.5–19.5). The
materno-placental vascular bed was characterized in manipu-
lated mouse embryos (including transfer of normal and
tetraploid-complemented embryos to foster dams), differentiat-
ing normally functioning placentas from those undergoing
resorption. Since the macromolecular DCE-MRI and the
fluorescence analysis used here are enabled by the blood-borne
transport of the albumin-based contrast material, these methods
provide information on the endogenous flux of maternal blood
through the placentas examined. We suggest that macromolec-
ular DCE-MRI is a valuable tool for the functional in utero
phenotypic evaluation of the materno-placental circulation in
wild-type and genetically modified mice.
Materials and Methods
All animal experiments were approved by the Weizmann Institu-
tional Animal Care and Use Committee.
In Vivo Contrast-Enhanced MRI Studies
Pregnant female mice (ICR outbred mice, Harlan, Israel; 7–
10 weeks old) were analyzed by MRI on E10.5 (n=2, total of 15
embryos, vaginal plug = E0.5), E13.5 (n=2, total of 24 embryos),
and E18.5 (n=3, total of 21 embryos). Different groups of mice
were used at each stage of the pregnancy for the analysis. Female
ICR mice carrying transferred embryos, (n=7 ICR; C57Bl/6J (B6)
with native (four embryos) or tetraploid placentas (five embryos)),
were analyzed on E18.5 of pregnancy.
MRI experiments were performed on a horizontal 4.7 T Bruker
Biospec spectrometer (Karlsruhe, Germany) using a whole-body
birdcage rf coil, with a diameter of 7.5 cm. No quadrature detection
was applied. Mice were anesthetized with intraperitoneal injection of
75 mg/kg ketamine (Ketaset; Fort Dodge Laboratories, Fort Dodge,
IA, USA) and 3 mg/kg xylazine (XYL-M 2%; VMD, Arendonk,
Belgium) followed by the subcutaneous addition of about 30% of the
initial dose in order to prolong the anesthesia. Anesthetized mice were
placed in prone position on a polymethylmethacrylate (Perspex) board
so that the abdomen was at the center of the coil, immobilized using
adhesive tape and covered with a cloth blanket (to retain body
temperature). The magnet room was maintained at 25°C.
The BSA-based macromolecular contrast material, biotin–BSA–
Gd–DTPA (approximate MW is 82 kDa, relaxivity R1=135 mM
−1 s−1
per albumin), was prepared as reported previously [15, 20] and
injected through a tail vein catheter as bolus at 12 mg /mouse in
0.2 mL of phosphate-buffered saline (PBS).
A series of variable flip angle (FA), precontrast, T1-weighted three-
dimensional gradient echo (3D-GE) images was acquired to determine
the endogenous precontrast R1 (pulse FA 15°, 5°, 30°, 50°, 70°;
repetition time (TR) 10 ms; echo time (TE) 3.6 ms; two averages,
spectral width 50,000 Hz, FOV=5×5×5 cm, matrix 128×128×64,
zero filled to 128×128×128, voxel resolution 0.39 mm3, 2 min 43 s
between each image). For dynamic post-contrast imaging, consecutive
T1-weighted 3D-GE images were acquired from the time of biotin–
BSA–Gd–DTPA administration up to 13.58 min (pulse FA=15° and
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all other parameters are as stated above; five scans post-contrast were
collected). Fetal anatomy was derived from multi-slice spin echo
images (TR 2,000 ms; TE 11 ms, two averages, spectral width 50,000,
matrix 128×128, in-plane resolution 0.39 mm2, slice thickness 1 mm,
interslice distance 1.2 mm, 13 slices).
MR signal intensity and the precontrast R1 values (R1pre, derived
from the variable flip angle scans; Eq. 1) were used to derive the post-
contrast R1 values (R1post; Eq. 2) and the contrast material concentration
for each time point (Ct; Eq. 3), as reported previously [17], using
Paravision (Paravision 4, Bruker, Rheinstetten, Germany) and Matlab
(Matlab 7.6.0 (R2008a), The Math Works Inc., Natik, MA, USA).





¼ M0 sin a 1 e
TRR1pre = 1 cos aeTRR1pre 
M0 sin a 1 eTRR1postð Þ= 1 cos aeTRR1postð Þ
ð2Þ
Ct ¼ biotin BSAGdDTPA½ 
¼ r11 R1post  R1pre
  ð3Þ
where I is the signal intensity for each flip angle α and R1 is the
specific relaxivity of biotin–BSA–Gd–DTPA (135 mM−1 s−1 per
albumin). The analysis is based on the assumption that water exchange
between the fetal and maternal circulation is fast. The concentration






where the initial enhancement was derived from the ratio of
extrapolated contrast material concentration at time = 0 relative to
the concentration in the vena cava (C0/Cblood; initial enhancement).
The rate of change in contrast material concentration was scaled to
the concentration in the vena cava (ROE = rate of enhancement
with units of min−1). Values were calculated from manually
selected regions of interest (ROI); the ROI was chosen from the
inner part of each enhanced placenta using the third time point post-
contrast. For some of the placentas (in which there were move-
ments of the fetuses), the ROI was manually marked for each scan.
Fig. 2 shows a representative analysis of MRI data and ROI
selection. The initial enhancement gives an indication to the initial
blood volume that fills the materno-placental blood spaces, while
the rate of enhancement over time gives an indication on the
dynamics of albumin turnover in the placenta.
Since on E10.5, in contrast with E13.5 and E18.5, the decidua is still
a significant part of the placenta, it was taken into account when the ROI
was chosen for quantification. On E13.5 and specifically on E18.5, the
decidua is significantly smaller and less vascularized as compared to the
labyrinth. By choosing an ROI within the enhanced region of the
placenta, we were able to mostly avoid the deciduas and concentrate on
the labyrinth at E13.5 and E18.5. Placental volume was calculated by
quantifying the number of voxels from all the slices in which the
placenta appeared in the 3D-MRI data. Fetal length was calculated from
the mid-coronal or mid-sagittal MR images.
Maximal intensity projections and surface projections were
assembled using NIH image and Paravision, respectively.
Histology, Histochemistry, and Fluorescence
Microscopy
Prior to animal euthanasia, BSA labeled with 6-carboxy-X-rhod-
amine (BSA-ROX) was injected via the tail vein catheter
previously used for MRI for the histological detection of functional
blood vessels, as reported previously [20]. In a separate set of
experiments, carboxyfluorescein (BSA–FAM) was administered by
intravenous (i.v.) injection and the animals were euthanized by
cervical dislocation either 3.5 or 13.5 min after fluorescent contrast
material administration and placentas were retrieved for further
analysis. A macro view of fetuses and placentas was acquired using
regular and fluorescent light (Olympus SZX 12 microscope, Center
Valley, PA, USA, equipped with DP50 camera). Placentas were
fixed in Carnoy mixture, embedded in paraffin, and sectioned
serially at 4-μm thickness. The fluorescent contrast material was
detected using a fluorescent microscope (Zeiss Axioscope II, Yena,
Germany, Simple PCI software). The percentage of fluorescent
staining coverage in each field of view was calculated using ImageJ
software. Biotin–BSA–GdDTPA was detected by staining of
sections with avidin-Texas red (Invitrogen, Carlsbad, CA, USA)
[20]. Cell nuclei were fluorescently stained with 4′,6-diamidino-2-
phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA).
Embryo Transfer and Tetraploid
Complementation/Rescue
Tetraploid aggregation is an important tool frequently used for the
detection and prevention of in utero lethality of genetically modified
mice, which is secondary to defects in extra-embryonic tissues such as
the placenta. By doubling the ploidity at the two-cell stage through
electrofusion, tetraploid embryos cannot develop but can still contribute
to the extra-embryonic tissue when aggregated with the inner cell mass
(ICM) of diploid embryos (isolated at the blastocyst stage) [2–5]. The
results of this manipulation are embryos of one genetic background,
supported by placentas of a different genetic background. In the
experiments reported here, GFP-expressing embryos provided the
tetraploid placenta for the B6 embryos.
Embryo Collection and Culture
For superovulation, 3-week-old ICR females were injected intraper-
itoneally with 5 IU of pregnant mare serum gonadotropin (PMSG) and
46 h later with 5 IU of human chorionic gonadotropin (hCG). After hCG
injection, females were mated with B5/EGFP males [21]. The super-
ovulated females were euthanized 46–48 h after hCG (E1.5), and late,
two-cell embryos were collected by flushing the oviduct.
Five- to 6-week-old B6 females were superovulated with 5 IU of
PMSG and 10 IU of hCG and mated with B6 males. Females were
euthanized either on E2.5, and eight-cell embryos were isolated for
aggregation, or E3.5, when blastocysts were isolated for immunosurgery.
Immunosurgery
The trophectoderm layer of the diploid blastocysts (E3.5) was
removed by immunosurgery, thus isolating the ICM as previously
described [22].
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Production of Tetraploid Embryos
Two-cell embryos underwent electrofusion. Following a short
pulse, embryos were transferred to the incubator. After 24 h,
compacting four-cell-stage embryos were used for aggregation [23].
Aggregation of Tetraploid Embryo and Isolated
Inner Cell Masses
After the removal of the zona pellucida, single, isolated ICM was
sandwiched between two tetraploid embryos in an aggregation
plate. After 24-h incubation, blastocysts were transferred to the
uterus of E2.5 pseudopregnant ICR female, at eight to ten
blastocysts per uterine horn.
In the experiments in which embryo transfer only was
performed, E3.5 embryos were transferred to the uterus of E2.5
pseudopregnant ICR female, at eight to ten blastocysts per uterine
horn.
Statistical Analysis
A two-tailed unpaired Student’s t-test was applied for the analysis
of significance of the MRI and histological data. The data are
considered significant when PG0.05. Data are presented as mean
value ± standard error of the mean. Two-way ANOVA analysis was
applied for the fluorescence rate of enhancement.
Results
In Utero MRI Evaluation of Placental Size
and Maternal Blood Circulation
Pregnant mice were studied by macromolecular DCE-MRI
at three different stages (Fig. 1): E10.5 (n=2, 15 placentas,
dropout rate of 35%), E13.5 (n=2, 24 placentas, dropout rate
of 4%) and E18.5 (n=3, 21 placentas, dropout rate of 8%).
All placentas that were discarded from the analysis showed
bad fit, predominantly due to movements of the embryos,
which were more intense at E10.5.
Maximal intensity projections enabled the detection of
the maternal blood spaces including the embryonic placentas
(Fig. 1a–f). Placental volume (Fig. 1g) showed a threefold
increase from E10.5 (0.01±0.005 mL) to E13.5 (0.03±
0.0006 mL, P=1.17×10−12) and a threefold increase from
E13.5 to E18.5 (0.09±0.01 mL, P=3.9×10−12).
The initial contrast enhancement in the placenta (Fig. 1h)
revealed no significant change in the maternal blood volume
fraction between E10.5 (0.2±0.03) and E13.5 (0.15±0.02, P=
0.13). However, a considerable increase in the initial enhance-
ment (Fig. 1h), by 3.3-fold, was observed at E18.5 compared to
E13.5 (0.5±0.15, P=0.000016). These data show that, at mid-
pregnancy, the increase in total placental volume precedes the
increase in maternal blood volume fraction.
Follow-up of the dynamics of contrast enhancement for
13.5 min was used for the derivation of the rate of change in
contrast material concentration over time (Fig. 1i). At the early
stage of placental development (E10.5), a negative rate of
enhancement (−0.007±0.007 min−1) was observed, rather
than accumulation; there was a rapid rate of clearance of
albumin from the maternal circulation of the placenta which
was faster than the rate at which biotin–BSA–Gd–DTPA
was cleared from the circulation (Fig. 2). This clearance was
attenuated at E13.5 (−0.0016±0.0008 min−1). Towards the
end of pregnancy (E18.5), the contrast material accumulated
slowly in the materno-placental blood spaces due to the slow
exchange of maternal blood in the placenta resulting in a
positive rate of enhancement (0.005±0.0049 min−1). A
significant change was observed between all time points
detected (P=0.01 for E10.5 and E13.5 and P=0.004 for
E13.5 and E18.5). No enhancement could be detected in the
embryos at any stage.
Histological Analysis of Placental Initial
Enhancement and Rate of Enhancement Over
Time
The MRI data was validated using the analogous fluorescent
macromolecular contrast agent BSA–FAM. Pregnant ICR
mice at different stages of pregnancy [E10.5 (n=3, nine
embryos), E13.5 (n=3, 13 embryos) and E18.5 (n=2, seven
embryos)] were administered with BSA–FAM (5 mg in PBS
i.v.) and euthanized either 3.5 or 13.5 min later. Placentas
were fixed and sectioned serially. The data in Fig. 3 show
that the contrast material is retained in the maternal blood
spaces with no transfer of the contrast media to the fetal
circulation. This indicates that our analysis is of the maternal
part of placental circulation and that the positive rate of
contrast agent accumulation at E18.5 does not represent
vascular permeability.
Based on this finding, we analyzed the fluorescent data
for changes in the distribution of contrast media that can
explain the clearance observed in the early-stage placenta
versus the accumulation observed in the late-stage placenta.
Analysis of the percentage of fluorescent area coverage in
each field of view retrieved from animals euthanized 3.5 min
post-injection (Fig. 3a–c) enabled a calculation of the initial
rate of enhancement in placenta. A 1.4-fold increase in the
initial enhancement (Fig. 3g) in the labyrinth was observed
between E10.5 (11.33±1.68%) and E13.5 (15.5±4.18%, P=
0.015) as well as between E13.5 and E18.5 (20.77±5.05%,
P=0.02). However, in corroboration with the MRI data in
Fig. 1, when the decidua blood pools at E10.5 were taken
into account (E10.5 dec + lab, 15.08±1.18), there was no
significant difference between the initial enhancement at
E10.5 and E13.5 (P=0.13).
Comparison of the fluorescent area at 13.5 min (Fig. 3d–f)
and at 3.5 min after administration of BSA–FAM enabled the
calculation of the rate of enhancement. The calculation was
done by subtracting the mean percentage area coverage of
BSA–FAM positive blood vessels at 3.5 min from the mean
area at 13.5 min. A similar trend was observed as shown above
by MRI. Rapid clearance of the fluorescent contrast agent was
observed at E10.5 (mean −4.37%), compared with a slower
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clearance at E13.5 (mean −1.77%). At E18.5, no clearance was
detected (mean 2.43%) and the contrast agent accumulated
slowly within the materno-placental blood spaces (Fig. 3h,
two-way ANOVA, F2,25=10.87, P=7.1×10
−9, post-hoc anal-
ysis: E10.5 vs. E13.5: P=2.45×10−4; E10.5 vs. E18.5: P=
8.47×10−9; E13.5 vs. E18.5: P=2.29×10−4).
Hematoxylin and eosin (H&E)-stained placentas of the
various developmental stages show the development of the
maternal blood spaces in the labyrinth and decidua (Fig. 3i–k).
Branching morphogenesis occurs at the chorioallantoic inter-
face specifically at E13.5 as compared to the smaller size and
shallow interdigitation of the maternal blood spaces on E10.5.
However, at E10.5, the area of the blood pools in the decidua is
relatively large to that of the labyrinth: the labyrinth is 46% the
size of the decidua. At E13.5 and E18.5, the decidua is
significantly smaller and less vascularized as compared to the
labyrinth; the labyrinth is 5.75 times the size of the decidua at
E13.5 and 14.5 times at E18.5. By E18.5, the labyrinth had
reached its full size and largest volume fraction [24].
Since the MR contrast material enhances the maternal side
of the placenta, i.e., the maternal blood spaces, at E10.5, the
MRI data in Fig. 1 represents both the labyrinth and the
Fig. 1. In utero MRI evaluation of placental size, initial enhancement, and rate of enhancement during different embryonic
stages (E10.5, E13.5, E18.5). a–c Maximal intensity projections of pregnant ICR mice, tail vein injected with biotin–BSA–Gd–
DTPA at E10.5, E13.5, or E18.5 respectively. K, kidney; B, bladder; VC, vena cava. d–f Surface projections of a–c, respectively.
Placentas are indicated with an arrow. g Calculation of the placental size (in mL) at different developmental stages. h
Calculation of the initial enhancement in the placenta (calibrated to the vena cava) at different developmental stages. i
Calculation of placental rate of enhancement at different developmental stages.
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decidua blood pools, as exemplified by the initial enhancement
calculated both for the labyrinth and the decidua relative to the
area of each compartment. The rate of enhancement at E10.5 is
similar for both compartments, as also seen in the MRI data in
Fig. 1. At E13.5 and E18.5, the MRI data in Fig. 1 represents
only the maternal blood in the labyrinth, as illustrated by the
size of the labyrinth in the histology.
The rapid clearance of the MRI and fluorescence contrast
materials from the maternal circulation at E10.5, E13.5, and
E18.5 was examined (Fig. 3l–n). The biotin–BSA–Gd–
DTPA was allowed to circulate for 50 min and, just before
animal euthanasia, BSA–FAM was injected. As can be seen,
both the endothelial cells in E10.5 decidua as well as the
multicellular syncytiotrophoblasts and the E13.5 labyrinth
have internalized biotin–BSA–Gd–DTPA (stained with
avidin-Texas red) while the BSA–FAM (green) is still
located within the vessel lumen. At E18.5, the early (red)
and late (green) contrast materials co-localize (yellow)
within the maternal blood spaces, implying an accumulation
of the contrast material within this compartment. Therefore,
the internalization of albumin at early developmental stages
is partly due to the contrast material uptake from the
placental blood spaces. This uptake can also be observed at
the later stage (E18.5), but it is confounded by the gradual
accumulation of the contrast material in the maternal blood
spaces.
Resolving Strain-Specific Differences Using MRI
In order to elaborate the capability of macromolecular DCE-
MRI for the evaluation of developmental changes in utero,
we examined strain-related differences using embryo trans-
fer experimentation (Fig. 4). B6 and ICR embryos were
segregated between the two uterine horns, so each strain was
transferred to a different uterine horn of a pseudopregnant
ICR mouse (n=2, eight B6 embryos, 12 ICR embryos).
Fig. 2. MRI quantification analysis and ROI selection. a Representative analysis of signal intensity over time in E10.5 placenta
and maternal vena cava before (time=0) and following injection of biotin–BSA–Gd–DTPA. b Surface projection of a placenta
marked with a ROI.
Fig. 3. Histological analysis of maternal albumin turnover in
the mouse placenta. Fluorescent images of placental laby-
rinth histological sections retrieved from E10.5, E13.5, and
E18.5 embryos, respectively. For E10.5, the inserts are of the
decidua blood pools (at the same magnification as the
labyrinth) (a–f). a–c Placentas were retrieved for histology
3.5 min following tail vein injection of BSA–FAM to the
pregnant mother. Blue, DAPI. Green, BSA–FAM. d–f Placen-
tas were retrieved for histology 13.5 min following tail vein
injection of BSA–FAM to the pregnant mother. Blue, nuclear
staining with DAPI. Green, BSA–FAM. g Calculation of the
initial enhancement inside the placenta at different devel-
opmental stages. h Calculation of the placental rate of
enhancement by the fluorescent contrast agent at different
developmental stages. Please note that, for E10.5, the
histograms show the calculations for the labyrinth (lab) and
decidua blood pools (dec) separately and the combined
values of the two compartments (dec + lab). i–k H&E-stained
placentas of the respected developmental stages exemplify
the development of the maternal blood spaces in the
labyrinth (lab) and decidua blood pools (dec). l–n Placentas
were retrieved 50 min post-injection of biotin–BSA–Gd–
DTPA via a tail vein (stained with avidin-Texas red) which
was followed by BSA–FAM (green) injected through the same
catheter 3.5 min prior to animal euthanization. Blue, DAPI.
Arrows, uptake of biotin–BSA–Gd–DTPA into intracellular
vacuoles detected using avidin-Texas red.
b
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E18.5 embryos were scanned (Fig. 4a–d) and analysis of fetal
and placental size, as well as placental initial enhancement and
rate of enhancement, was carried out. Using the MRI data, a
significant difference was observed in fetal size (Fig. 4f), as
ICR embryos were found to be 1.3-fold larger than B6
embryos (2.28±0.05 and 1.75±0.09 cm, respectively; P=
0.001). This difference was verified following animal eutha-
nasia and retrieval of the embryos (Fig. 4e). In agreement with
the change in fetal size, placental size (Fig. 4g) was found to be
significantly larger in ICR vs. B6 embryos (1±0.06 and 0.72±
0.08 mL, respectively; P=0.03). Interestingly, a tendency
towards higher values in the placental initial and rate of
enhancement in the ICR embryos was observed in these
analyses (Fig. 4h). Strain-related changes in the initial enhance-
ment (ICR, 0.46±0.09; B6, 0.35±0.06; P=0.36) and rate of
enhancement (ICR, 1.04±0.24 min−1; B6, 0.58±0.37 min−1;
P=0.09; Fig. 4i) were not significant.
MRI Detection of Normally Functioning
Tetraploid Placentas Versus Placental Vascular
Resorptions
Some genetically modified mouse models and manipulation
in mouse embryos lead to death in utero, which could be
reflected in impaired placental development. During preg-
nancy, pathological circumstances may lead to resorption of
both the embryo and its placenta. As the process occurs
gradually, partially perfused placentas can be found in the
uterus even after the embryo was already resorped. We
applied ex vivo fluorescence imaging for the validation of
the in vivo macromolecular DCE-MRI for the detection and
evaluation of placental pathologies.
The different physiological states are exemplified in
Fig. 5. Fully vascularized placentas attached to healthy
embryos were visualized both by intravenous administration
of BSA-ROX to pregnant ICR mice E18.5 (Fig. 5a–d) and
by macromolecular DCE-MRI (Fig. 5g). However, a fully
resorped unvascularized placenta could not be imaged
following BSA-ROX i.v. injection (Fig. 5a, b). Interestingly,
a partially perfused placenta attached to a fully resorped
embryo could be detected by both fluorescent imaging and
Fig. 4. Resolving strain differences using MRI. a, c Surface projections of a pregnant ICR mouse carrying E18.5 B6 and ICR
transferred embryos, tail vein injected with biotin–BSA–Gd–DTPA. Placentas are indicated with an arrow. Embryos are
indicated with an asterisk. b, d T2-weighted images of a and c prior to contrast material injection. Placentas are indicated with
an arrow. Embryos are indicated with an asterisk. d Embryos’ eyes are indicated with arrowheads. e Ex vivo demonstration of
B6 and ICR E18.5 embryos. f Calculation of the B6 and ICR fetal size (cm). g Calculation of B6 and ICR placental size (mL). h
Calculation of placental initial enhancement for B6 and ICR placentas. i Calculation of placental rate of enhancement for B6 and
ICR placentas.
Fig. 5. Macromolecular contrast material detects vascular
resorptions. a, b Light microscopy (a) and fluorescence
microscopy (b) of the same embryo. BSA-ROX (red) is
excluded from a fully resorped placenta (arrows in a and b).
c, d Functional placentas of resorped fetuses are perfused.
e, f Tetraploid resorption (left) and a fetus that died in utero
and its tetraploid GFP placenta (right). g, h MRI detection of
biotin–BSA–Gd–DTPA of c and d versus e and f, respec-
tively. i The fetus in e, f, and h that died in utero prior to the
MR scan shown (right) versus a normal E18.5 fetus (left). Tails
were removed for genotyping. j Initial enhancement fraction
in vascularized resorped placentas was significantly
decreased as compared to regular (C57BL/6 J) and tetraploid
(GFP-positive) placentas. Specifically, initial enhancement
was decreased in both fully resorped fetuses (fetus absent,
w/o F) and placentas of dead fetuses (fetus present, w F).
Red boxes show resorption data—the left bar graph shows
all resorption and the right bar graph shows the two different
resorption types. There was no difference in initial enhance-
ment between regular and tetraploid placentas. p, placenta;
mbv, myometrial blood vessels; F, fetus; small arrowheads,
fully resorped fetus; large arrowheads, a vascularized resorp-
tion site.
b
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by MRI (see arrowhead in Fig. 5c, d, and g). Hence, using
macromolecular DCE-MRI, we were able to non-invasively
detect both fully and partially perfused placentas.
In order to independently assess the viability of the placenta,
tetraploid complementation was carried out. Using this
method, one may generate an embryo of a specific genetic
background, bearing a placenta of a different genetic back-
ground. In this study, we generated embryos in which only the
tetraploid placenta expressed GFP, enabling differentiation of
tetraploid placentas from regular placentas. As shown in
Fig. 5e and f, an apparently normal tetraploid placenta could
be clearly distinguished from a partially resorped placenta.
A major challenge in placental imaging is non-invasive in
utero detection of recently resorped fetuses. It will allow the
in utero evaluation of the viability of genetically modified
mice or the success of manipulations in mouse embryos. In
these cases, even though the embryo is dying, it might look
normal in the MRI scan or even ex vivo. Fig. 5h presents an
MRI image of the same embryos shown in Fig. 5e and f. The
placenta of the resorped fetus can be distinguished easily
from that of the apparently healthy fetus. However, even
though both the unresorped embryo and its placenta appear
anatomically normal, an analysis of the MRI data derived
from the placenta revealed a significantly lower value for the
initial enhancement (Fig. 5h; initial enhancement = 0.06 for
this specific resorped placenta), indicating that both the
embryo and its placenta are undergoing resorption. This
phenomenon was consistent with significantly reduced
initial enhancement values measured for other vascularized
resorptions as compared to regular (C57BL/6J) and tetra-
ploid (GFP-positive) placentas (resorptions: n=8 in seven
dams; tetraploid: n=5 in four dams, P=0.04 and B6: n=4 in
two dams, P=0.001; Fig. 5j). Decreased initial enhancement
was exhibited in both fully resorped fetuses (fetus absent;
w/o F, n=6 in five dams) and in placentas of dead fetuses
(fetus present; w F, n=2 in two dams).
Discussion
The placenta is an extra-embryonic tissue that permits the
embryo to develop within the female reproductive tract.
Considering the increasing interest in phenotypic analysis of
genetically modified mice, functional analysis of placental
vascularization during pregnancy may serve as an important
tool for understanding the role and function of genes. It is
currently challenging to evaluate placental circulation in
utero in mice [25]. 3D reconstruction of the fetoplacental
circulation architecture was reported using vascular corro-
sion casts [11]. Despite the ability of this method to display
the intricate structure of the placenta, data quantification
derived from casts may be problematic as superficial
vasculature obscures the deeper structures [26]. Stereology
of histological sections has been used to obtain quantitative
3D measures of placental vascularity [24, 27], but sectioning
permanently destroys the connectivity between vessels and
hence the overall topology. Both corrosion casting and
histology provide anatomical structures but cannot be used
for longitudinal, functional monitoring of mice in vivo.
Micro-CT was shown to provide exquisite images of rat
pregnancy [28] as well as enabled 3D visualization and
quantification of arterial and venous feto-placental vascula-
ture in the mouse [26]. However, serial dynamic micro-CT
imaging would result in biologically unacceptable radiation
exposure and thus cannot be applied for in vivo imaging.
Non-invasive imaging of the mouse placenta was also
carried out using high-frequency ultrasound. This method
was mainly used to generate high-resolution anatomical
images of the mouse embryo and placenta from implantation
to term [29–31] and to enable the monitoring of changes in
hemodynamics of uterine artery, utero- and umbilicoplacental
and vitelline circulations [29, 32]. However, both high-
frequency and Doppler ultrasound are limited in allowing a
direct quantification of the materno-placental perfusion [18].
A few MRI studies were carried out in mice in order to
measure tissue blood flow and vascular permeability as well
as to characterize the effect of noradrenaline on placental
blood flow [19, 33]. These studies took advantage of the low
molecular weight and small particle diameter of the
gadolinium chelate, gadoterate meglumine, in order to
investigate the blood flow and placental transport between
the mother and its fetuses.
In the current study, we analyzed in utero maternal
placental vascularization at different developmental stages.
As expected, increase in placental size and vessel density
was observed along the pregnancy. Interestingly, whereas
a significant increase in placental size was observed by
MRI at early stages of the pregnancy (E10.5 and E13.5),
no significant difference in the initial enhancement was
observed, suggesting that the fetus’ demands for nutrients
and waste evacuation are adequately compensated by the
change in placental size during this period. Only as the
pregnancy advances (E13.5 to E18.5) does a remarkable
expansion of the maternal blood volume fraction in the
placenta take place in order for the fetus to develop
normally. In agreement with our MRI data, the histological
analysis revealed only a minor difference in the initial
enhancement for early developmental stages (for the
labyrinth and decidua which are the placental compart-
ments supplying the fetus at this time). A major increase
in placental vascularization was observed between the
early (E10.5, 13.5) and late (E18.5) stages of the fetus
development.
Following the rate of contrast enhancement dynamics,
both MRI and fluorescence analysis revealed additional
changes in the maternal circulation of the placenta during
pregnancy that demonstrate the marked difference of the
placenta from other processes of vascular expansion
associated with angiogenesis. Angiogenesis is typically
characterized by a gradual increase in the concentration of
contrast material which is attributed to vascular hyper-
permeability, and upon fitting of the data to a two-compart-
ment exchange model it is possible to derive the blood
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volume fraction and the permeability surface area product
[15, 34–36]. However, in the late-stage placenta, accumu-
lation of the contrast material occurred without any
permeability or extravasation of the contrast material from
the maternal circulation to the interstitial space and no
transfer of the contrast material to the embryo. Thus, the
macromolecular DCE-MRI data could not be analyzed using
the available pharmacokinetic models.
In the absence of permeability of the maternal blood
spaces in the placenta, dynamic changes in the concentration
of the contrast material reflect either its clearance or
accumulation within the maternal circulation of the placenta.
Significant changes were observed throughout the preg-
nancy, starting with fast clearance detected at early stages
followed by a slow accumulation towards the end of the
pregnancy. The delayed elevation in maternal vessel density
as compared to the significantly increased ability of the
maternal side of the placenta to retain the contrast material at
mid-pregnancy (E10.5 to E13.5) may be partially explained
by the branching morphogenesis which occurs within the
chorioallantoic interface which gives rise to the placental
labyrinth [37]. At E13.5, branching morphogenesis has
progressed, allowing for a slower outflow of blood from
the materno-placental blood spaces although the absolute
volume of blood vessels in the forming labyrinth has yet to
change. Indeed it was previously reported using stereo-
logical methods that the absolute volume of the maternal
blood spaces in the labyrinth is rapidly expanding after
E13.5, between E14.5 and E16.5 [24]. By the end of
pregnancy (E18.5), the labyrinth is fully functioning, as it
delivers maximum maternal blood into the placenta and also
retains this blood over time to allow an effective exchange of
oxygen and nutrients with the fetal blood. In this sense, the
functional readout from macromolecular DCE-MRI corre-
lates well with the normal stages of placental development
and therefore could aid in the non-invasive evaluation of
the impact of impaired placental development during
pregnancy.
The rapid clearance of the MRI and fluorescence contrast
materials from the maternal circulation at E10.5 and E13.5
was found to be much faster than the clearance from the
plasma (vena cava), and this could only be explained by
active uptake. Indeed the albumin-based contrast materials
are actively internalized by endothelial cells in the decidua
and by trophoblast giant cells as well as syncytiotrophoblasts
in the labyrinth. The multinucleated syncytiotrophoblasts
may serve as a selective barrier or regulator of nutrient,
metabolite, gas, waste, and immune interchange between the
circulatory systems of mother and fetus [37]. Albumin
uptake by trophoblasts by the apical recycling pathway
was recently reported for the human placenta [38, 39] and
albumin could also be taken up by other trophoblast cell
types in the mouse placenta such as the sinuosoidal
trophoblast giant cells [40].
Intracellular endocytic uptake of biotin–BSA–Gd–
DTPA will differentially affect its detection by MRI and
by fluorescence microscopy. As we reported previously,
internalization of biotin–BSA–Gd–DTPA into endosomes
effectively abolished its R1 relaxivity [15, 20, 41, 42]. The
localization of internalized albumin conjugated to fluo-
rescence molecules in vacuoles will also decrease the
fluorescence signal within the maternal blood space, but
the vacuoles will be intensely labeled. The rate of
enhancement thus reveals the steady state of maternal
albumin between active apical recycling and albumin
delivery by the placental circulation.
Dynamic contrast-enhanced MRI allowed us to resolve
strain-related differences in embryo transfer procedures and
to detect pathological conditions. Analysis of ICR versus B6
embryos revealed a significant difference in their size. ICR
embryos were found to be larger than B6 embryos and,
accordingly, their placentas were larger as well. Interest-
ingly, these changes in size were not accompanied by a
significant difference in either the initial enhancement or rate
of enhancement values, although a mild increase in these
parameters was observed for the ICR strain. This indicated
that the nutritional demands of the two strains are not
significantly different.
The utility of macromolecular DCE-MRI for the analysis
of impaired placental vascularization was examined as well.
Placentas at different stages of resorption were distinguished
in utero from healthy placentas, yielding information on the
physiological state of the embryo. Specifically, macro-
molecular DCE-MRI was able to differentiate normal
placentas from placentas undergoing resorption, still con-
nected to dead fetuses. These resorping placentas are
enhanced after the administration of the contrast media,
similarly to normal placentas, but their initial enhancement is
similar to that of vascular resorption which has no fetus
attached. This MRI methodology may therefore be utilized
to follow up on the embryonic physiological state in normal
pregnancies in utero as well as in manipulated techniques
such as tetraploid complementation and embryo transfer
experimentation.
In summary, the data presented here suggests the use of
macromolecular DCE-MRI as a tool for in utero phenotypic
evaluation of the impact of the fetal genotype on the
maternal albumin turnover in the placenta.
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